Publication: Enhanced Efflux Activity Facilitates Drug Tolerance in Dormant Bacterial Cells
Open/View Files
Date
2016
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Cell Press
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Pu, Y., Z. Zhao, Y. Li, J. Zou, Q. Ma, Y. Zhao, Y. Ke, et al. 2016. “Enhanced Efflux Activity Facilitates Drug Tolerance in Dormant Bacterial Cells.” Molecular Cell 62 (2): 284-294. doi:10.1016/j.molcel.2016.03.035. http://dx.doi.org/10.1016/j.molcel.2016.03.035.
Research Data
Abstract
Summary Natural variations in gene expression provide a mechanism for multiple phenotypes to arise in an isogenic bacterial population. In particular, a sub-group termed persisters show high tolerance to antibiotics. Previously, their formation has been attributed to cell dormancy. Here we demonstrate that bacterial persisters, under β-lactam antibiotic treatment, show less cytoplasmic drug accumulation as a result of enhanced efflux activity. Consistently, a number of multi-drug efflux genes, particularly the central component TolC, show higher expression in persisters. Time-lapse imaging and mutagenesis studies further establish a positive correlation between tolC expression and bacterial persistence. The key role of efflux systems, among multiple biological pathways involved in persister formation, indicates that persisters implement a positive defense against antibiotics prior to a passive defense via dormancy. Finally, efflux inhibitors and antibiotics together effectively attenuate persister formation, suggesting a combination strategy to target drug tolerance.
Description
Other Available Sources
Keywords
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service